Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-142027

Director sold 9,000 shares at $19.06 ($171,540)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lingnau Lutz · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-15 Sale : show line 1 in the form −9,000 $19.06 $171,540 7,450 D
2016-09-15 Exercise or conversion : show line 2 in the form +15,000 22,450 D
Open-market sales · 9,000 sh · avg $19.06 · $171,540

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2016-09-15 Exercise or conversion : show line 3 in the form Restricted Stock Unit −15,000 15,000 0 D
Loading xslF345X03/doc4.xml…